We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.2B
AUM Growth
-$730M
Cap. Flow
-$164M
Cap. Flow %
-5.14%
Top 10 Hldgs %
14.44%
Holding
1,433
New
85
Increased
447
Reduced
621
Closed
196

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$7.65M
2
VZ icon
Verizon
VZ
+$4.92M
3
LIN icon
Linde
LIN
+$4.78M
4
ILMN icon
Illumina
ILMN
+$4.5M
5
AAPL icon
Apple
AAPL
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 13.46%
2 Technology 12.76%
3 Financials 11.37%
4 Industrials 8.31%
5 Consumer Discretionary 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APC
326
DELISTED
Anadarko Petroleum
APC
$2.12M 0.07%
48,429
+1,753
+4% +$98.9K
TSLA icon
327
Tesla
TSLA
$1.3T
$2.12M 0.07%
95,325
+10,650
+13% +$229K
HSY icon
328
Hershey
HSY
$36.6B
$2.1M 0.07%
19,612
-361
-2% -$38.4K
AYI icon
329
Acuity Brands
AYI
$10.8B
$2.1M 0.07%
18,271
+13,059
+251% +$1.61M
AEP icon
330
American Electric Power
AEP
$68.4B
$2.07M 0.06%
27,735
-412
-1% -$30.9K
ALB icon
331
Albemarle
ALB
$15.5B
$2.07M 0.06%
26,863
-23,994
-47% -$2.26M
IWD icon
332
iShares Russell 1000 Value ETF
IWD
$83.9B
$2.04M 0.06%
18,385
-2,031
-10% -$243K
WBA
333
DELISTED
Walgreens Boots Alliance
WBA
$2.02M 0.06%
29,619
+403
+1% +$31.3K
PTLC icon
334
Pacer Trendpilot US Large Cap ETF
PTLC
$3.37B
$2.02M 0.06%
70,265
+24,710
+54% +$726K
ETG
335
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.85B
$2.02M 0.06%
149,109
+51,924
+53% +$804K
UDR icon
336
UDR
UDR
$12.3B
$2.02M 0.06%
50,909
+5,013
+11% +$203K
FDC
337
DELISTED
First Data Corporation
FDC
$2.01M 0.06%
118,627
-7,116
-6% -$139K
EVH icon
338
Evolent Health
EVH
$447M
$1.99M 0.06%
99,888
+40,395
+68% +$935K
SYY icon
339
Sysco
SYY
$40.3B
$1.99M 0.06%
31,762
-139
-0.4% -$9.37K
AMD icon
340
Advanced Micro Devices
AMD
$789B
$1.98M 0.06%
107,442
+3,151
+3% +$68.1K
ETN icon
341
Eaton
ETN
$174B
$1.96M 0.06%
28,556
-246
-0.9% -$18.4K
WELL icon
342
Welltower
WELL
$171B
$1.96M 0.06%
28,239
-334
-1% -$22.7K
AMBR
343
DELISTED
Amber Road Inc
AMBR
$1.96M 0.06%
237,943
TEVA icon
344
Teva Pharmaceuticals
TEVA
$41.2B
$1.95M 0.06%
126,639
-1,639
-1% -$33.6K
EQR icon
345
Equity Residential
EQR
$25.1B
$1.95M 0.06%
29,514
+5,414
+22% +$364K
SONY icon
346
Sony
SONY
$138B
$1.92M 0.06%
199,095
+6,125
+3% +$64.8K
CCI icon
347
Crown Castle
CCI
$32.2B
$1.9M 0.06%
17,518
+2,545
+17% +$280K
ET icon
348
Energy Transfer Partners
ET
$69.3B
$1.89M 0.06%
142,942
+121,561
+569% +$1.85M
AIG icon
349
American International
AIG
$41.3B
$1.87M 0.06%
47,493
+555
+1% +$24.2K
RY icon
350
Royal Bank of Canada
RY
$293B
$1.87M 0.06%
27,267
-2,018
-7% -$147K

Similar funds

Oppenheimer & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Oppenheimer & Co held 1,433 positions worth $3.2B, down 19% from $3.93B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $164M in Q4 2018, closing 196 positions and reducing 621 holdings. Its most notable exit was Etsy, an estimated $6.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, Oppenheimer & Co opened a new position in Linde worth $4.72M.

  • Oppenheimer & Co's largest Q4 2018 buy was Linde: 30,256 shares worth $4.72M.
  • Oppenheimer & Co added most to iShares 20+ Year Treasury Bond ETF in Q4 2018, an estimated $7.65M increase.
  • Oppenheimer & Co's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $9.23M.
  • Oppenheimer & Co fully exited Etsy in Q4 2018, selling an estimated $6.87M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.2B portfolio in Q4 2018.
  • Oppenheimer & Co opened 85 new positions and closed 196 in Q4 2018.
  • Oppenheimer & Co's portfolio value fell 19% quarter-over-quarter to $3.2B.

Based on Oppenheimer & Co's 13F filing for Q4 2018, filed 29 Jan 2019.